Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_provenance.
- NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_assertion description "[We found a distinct p73 expression profile with highest p73 mRNA transcript levels in hematopoietic malignancies such as CML blast crisis and acute myelogenous leukemia versus CML chronic phase and normal controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_provenance.
- NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_assertion evidence source_evidence_literature NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_provenance.
- NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_assertion SIO_000772 10485463 NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_provenance.
- NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_assertion wasDerivedFrom befree-20140225 NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_provenance.
- NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_assertion wasGeneratedBy ECO_0000203 NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP704285.RAGFdX_XLIC99o7tU5Fp1sgb13VYzS1o1gkVxfm6MU-V0130_provenance.